Life Science

Construction of Recombinant Eukaryotic Expression Vector for PinX1 and Its Roles in Inhibiting Proliferation of Human Breast Cancer MCF-7 Cell Line

Expand
  • 1. Bio-electronic Center, Shanghai University, Shanghai 200444, China; 2. Institute of Genetic Engineering, South Medical University, Guangzhou 510515, China; 3. South China Genomics Research Center, Guangzhou 510800, China

Online published: 2013-12-30

Abstract

This paper explores the effects of PinX1 gene on the growth and the cell cycles of breast carcinoma cell line MCF-7 and the potential in treatment of breast cancer. The PinX1 mRNA was amplified from 293-T cell with RT-PCR and inserted into pEGFP-C1 vector. The recombined eukaryotic expression vector of PinX1 was confirmed by enzyme digestion, and transfected into the breast carcinoma cell line MCF-7 using a liposome method. The expressed mRNA was detected by real-time PCR, and the cell growth and cell cycles by MTT and flow cytometry, respectively. Results showed that PinX1 transfection into the breast cancer MCF-7 cell line was stable and the transfected gene was integrated into nucleolus DNA of transfected cells. Transfection of PinX1 gene could  significantly inhibit the growth and proliferation of breast cancer cells (P < 0.05) and the cell growth was arrested at G0/G1 stage. The conclusion is that PinX1 gene could inhibit growth and proliferation of breast cancer cells.

Cite this article

HU Zong1, LIANG Sang-hua2, MA Wen-li1,2, ZHENG Wen-ling1,3 . Construction of Recombinant Eukaryotic Expression Vector for PinX1 and Its Roles in Inhibiting Proliferation of Human Breast Cancer MCF-7 Cell Line[J]. Journal of Shanghai University, 2013 , 19(6) : 631 -635 . DOI: 10.3969/j.issn.1007-2861.2013.06.015

References

[1] Blasco M A. Telomeres and human disease: ageing, cancer and beyond [J]. Nat Rev Genet, 2005, 6(8): 611-622.

[2] Zhou X Z, Lu K P. The Pin2 /TRF1 interacting protein PinX1 is a potent telomerase inhibitor [J]. Cell, 2001, 107 (3): 347-359.

[3] Liao C, Zhao M J, Song H, et al. Identification of the gene for a novel liver-related putative tumor suppressor at a high frequency loss of heterozygosity region of chromosome 8p23 in human hepatocellular carcinoma [J]. Hepatology, 2000, 10: 721-722.

[4] 孙文旦. PinX1 基因真核表达载体的构建及其在Hek293 细胞中的表达[J]. 临床检验, 2009, 27: 445-447.

[5] Won S P, Jong H L, Jik Y P, et al. Genetic analysis of the liver putative tumor suppressor gene in hepatocelluar carcinomas [J]. Cancer Let, 2002, 178(2): 199-207.

[6] de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres [J]. Genes Dev, 2005, 19(18): 2100-2110.

[7] van Steensel B, De Lange T. Control of telomere length by the human telomeric protein TRF1 [J]. Nature, 1997, 385: 740-743.

[8] Chong L, Van S B, Broccoli D, et al. A human telomeric protein [J]. Science, 1995, 270(5242): 1663-1667.

[9] Ancelin K, Brunori M, Bauwens S, et al. Targeting assay to study the cis functions of human telomeric proteins: evidence for inhibition of telomerase by TRF1 and for activation of telomere degradation by TRF2 [J]. Mol Cell Biol, 2002, 22(10): 3474-3487.

[10] Soohoo C Y, Shi R, Lee T H, et al. Telomerase inhibitor PinX1 provides a link between TRF1 and telomerase to prevent telomere elongation [J]. J Biol Chem, 2011, 286: 3894-3906.

[11] Zhou X Z, Huang P, Shi R, et al. The telomerase inhibitor PinX1 is a major haploinsufficient tumor suppressor essential for chromosome stability [J]. J Clin Invest, 2011, 121: 1266-1282.

[12] Chen G, Da L, Wang H, et al. HIV-Tat-mediated delivery of an LPTS functional fragment inhibits telomerase activity and tumorigenicity of hepatoma cells [J]. Gastroenterology, 2011, 140(1): 332-343.

[13] Zhang L, Jiang Y, Zheng Y, et al. Selective killing of Burkitt’s lymphoma cells by mBAFF-targeted delivery of PinX1 [J]. Leukemia, 2011, 25(2): 331-340.

[14] Wang H B, Wang W Q, Wang X W, et al. PinX1 gene transfection enhances the sensitivity of gastric carcinoma cell line to 5-fluorouracil [J]. Hepatogastroenterology, 2011, 58(106): 682-686.

[15] Harley C B. Telomerase and cancer therapeutics [J]. Nat Rev Cancer, 2008, 8(3): 167-179.

[16] Joseph I, Tressler R, Bassett E, et al. The telomerase inhibitor imetelstat depletes cancer stem cells in breast and pancreatic cancer cell lines [J]. Cancer Res, 2010, 70(22): 9494-9504.
Outlines

/